This website and the information contained therein do not constitute an offer to sell or a solicitation of an offer to buy any mandatory convertible bonds and/or convertible shares (the “securities”) of Epigenomics AG in the United States of America (“U.S.”) or in any other jurisdiction or to any person if such offer or solicitation is unlawful or not authorized. Users of this website are requested to inform themselves about and to observe any such restrictions. The information set forth on this website must not be distributed in or to the U.S., to “U.S. persons” as defined in Regulation S under the U.S. Securities Act of 1933, as amended (the “Securities Act”), or to publications with a general circulation in the U.S. Each violation of such limitations may constitute a violation of applicable securities laws.
The subscription rights and the securities of Epigenomics AG described herein have not been and will not be registered under the Securities Act or the securities laws of any state of the U.S. and may not be offered or sold in the U.S. unless pursuant to an exemption from registration requirements. There will be no public offering of the securities in the U.S, Australia, Japan, Canada or South Africa and subscription rights held by persons who are resident of the U.S. may only be exercised upon confirmation of the following warranties: (a) it understands that the subscription rights and the securities have not been and will not be registered under the under the Securities Act or any other applicable U.S. state securities laws and are being offered and issued or sold in a transaction not involving a public offering in the U.S., that is exempt from the registration requirements of the Securities Act; (b) it is acquiring the subscription rights and the securities, as the case may be, for investment purposes and not with a view to any distribution (within the meaning of the U.S. federal securities laws) of the securities; (c) it understands that the subscription rights and the securities are restricted securities within the meaning of Rule 144(a)(3) of the Securities Act; and (d) it will not transfer any of the subscription rights and securities except in compliance with Regulation S under the Securities Act or pursuant to an effective registration statement under the Securities Act. The acceptance of the offer of the mandatory convertible bonds outside the Federal Republic of Germany (“Germany”) may be subject to restrictions.
By clicking on the “I agree” button below, you warrant that (a) you are located in, or a resident of, Germany, and (b) if you are located, or your residency is, outside Germany, you are (i) no “U.S. person” within the meaning of the Securities Act and (ii) you are located outside the U.S., Australia, Japan, Canada or South Africa or any other jurisdictions in which the distribution or release would be unlawful and (c) if you are located in, or a resident of, the U.S., you are a qualified institutional buyer within the meaning of the Securities Act or confirm the above warranties.